Literature DB >> 9237434

Vasodilatory responses and magnetic resonance angiography. Extracranial and intracranial intravascular flow data.

R L Levine1, P A Turski, W D Turnipseed, D A Dulli, T M Grist.   

Abstract

This study measured the responses of both extracranial (internal carotid arteries) and intracranial (middle cerebral/angular, basilar arteries) intravascular arterial volume flow rates to acetazolamide using phase-contrast magnetic resonance angiography. Twenty-eight newly studied patients were subdivided into four groups: Group I--Nonocclusive, asymptomatic (n = 7, or 14 carotid and middle cerebral/angular artery sides); Group II--unilateral carotid transient ischemic attacks, nonhemodynamic (embolic), varying stenoses (n = 11); Group III--unilateral carotid transient ischemic attacks, hemodynamic, varying stenoses (n = 5); and Group IV--unilateral carotid occlusion, asymptomatic (n = 5). The data were separated into nonischemic and ischemic sides so as to illustrate group differences based on vasodilatory responses to acetazolamide. For example, the percent change in volume flow rates over baseline values for the ischemic-side middle cerebral arteries of Group III was significantly the lowest of all of the vasodilatory responses (-25 +/- 11% vs 40 +/- 14% for group II ischemic middle cerebral/angular artery sides, p = 0.008). Group III patients also had significantly lower standing blood pressures (p = 0.012), higher number of transient ischemic attacks (p = 0.008), and shorter duration of events (p = 0.013). Determinations of volume flow rate continue to assist in determining the degree of hemodynamic compromise of a particular vascular territory.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237434     DOI: 10.1111/jon199773152

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  1 in total

1.  In vivo evaluation of quantitative MR angiography in a canine carotid artery stenosis model.

Authors:  M Calderon-Arnulphi; S Amin-Hanjani; A Alaraj; M Zhao; X Du; S Ruland; X J Zhou; K R Thulborn; F T Charbel
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.